These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 18221072)

  • 1. Non-steroidal LXR agonists; an emerging therapeutic strategy for the treatment of atherosclerosis.
    Bennett DJ; Cooke AJ; Edwards AS
    Recent Pat Cardiovasc Drug Discov; 2006 Jan; 1(1):21-46. PubMed ID: 18221072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of liver X receptor decreases atherosclerosis in Ldlr⁻/⁻ mice in the absence of ATP-binding cassette transporters A1 and G1 in myeloid cells.
    Kappus MS; Murphy AJ; Abramowicz S; Ntonga V; Welch CL; Tall AR; Westerterp M
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):279-84. PubMed ID: 24311381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of liver x receptor/retinoid X receptor-mediated transcription contributes to the proatherogenic effects of arsenic in macrophages in vitro.
    Padovani AM; Molina MF; Mann KK
    Arterioscler Thromb Vasc Biol; 2010 Jun; 30(6):1228-36. PubMed ID: 20339114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. II. LXRs suppress lipid degradation gene promoters through inhibition of PPAR signaling.
    Ide T; Shimano H; Yoshikawa T; Yahagi N; Amemiya-Kudo M; Matsuzaka T; Nakakuki M; Yatoh S; Iizuka Y; Tomita S; Ohashi K; Takahashi A; Sone H; Gotoda T; Osuga J; Ishibashi S; Yamada N
    Mol Endocrinol; 2003 Jul; 17(7):1255-67. PubMed ID: 12730332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver X receptor (LXR)-beta regulation in LXRalpha-deficient mice: implications for therapeutic targeting.
    Quinet EM; Savio DA; Halpern AR; Chen L; Schuster GU; Gustafsson JA; Basso MD; Nambi P
    Mol Pharmacol; 2006 Oct; 70(4):1340-9. PubMed ID: 16825483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. I. PPARs suppress sterol regulatory element binding protein-1c promoter through inhibition of LXR signaling.
    Yoshikawa T; Ide T; Shimano H; Yahagi N; Amemiya-Kudo M; Matsuzaka T; Yatoh S; Kitamine T; Okazaki H; Tamura Y; Sekiya M; Takahashi A; Hasty AH; Sato R; Sone H; Osuga J; Ishibashi S; Yamada N
    Mol Endocrinol; 2003 Jul; 17(7):1240-54. PubMed ID: 12730331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiatherosclerotic effects of a novel synthetic tissue-selective steroidal liver X receptor agonist in low-density lipoprotein receptor-deficient mice.
    Peng D; Hiipakka RA; Dai Q; Guo J; Reardon CA; Getz GS; Liao S
    J Pharmacol Exp Ther; 2008 Nov; 327(2):332-42. PubMed ID: 18723776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of LXR alpha in goose primary hepatocyte lipogenesis.
    Han C; Wang J; Li L; Wang L; Zhang Z
    Mol Cell Biochem; 2009 Feb; 322(1-2):37-42. PubMed ID: 18975056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic LXR agonist attenuates plaque formation in apoE-/- mice without inducing liver steatosis and hypertriglyceridemia.
    Kratzer A; Buchebner M; Pfeifer T; Becker TM; Uray G; Miyazaki M; Miyazaki-Anzai S; Ebner B; Chandak PG; Kadam RS; Calayir E; Rathke N; Ahammer H; Radovic B; Trauner M; Hoefler G; Kompella UB; Fauler G; Levi M; Levak-Frank S; Kostner GM; Kratky D
    J Lipid Res; 2009 Feb; 50(2):312-26. PubMed ID: 18812595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TTC39B deficiency stabilizes LXR reducing both atherosclerosis and steatohepatitis.
    Hsieh J; Koseki M; Molusky MM; Yakushiji E; Ichi I; Westerterp M; Iqbal J; Chan RB; Abramowicz S; Tascau L; Takiguchi S; Yamashita S; Welch CL; Di Paolo G; Hussain MM; Lefkowitch JH; Rader DJ; Tall AR
    Nature; 2016 Jul; 535(7611):303-7. PubMed ID: 27383786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery and implementation of transcriptional biomarkers of synthetic LXR agonists in peripheral blood cells.
    DiBlasio-Smith EA; Arai M; Quinet EM; Evans MJ; Kornaga T; Basso MD; Chen L; Feingold I; Halpern AR; Liu QY; Nambi P; Savio D; Wang S; Mounts WM; Isler JA; Slager AM; Burczynski ME; Dorner AJ; LaVallie ER
    J Transl Med; 2008 Oct; 6():59. PubMed ID: 18925943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chenodeoxycholic acid suppresses the activation of acetyl-coenzyme A carboxylase-alpha gene transcription by the liver X receptor agonist T0-901317.
    Talukdar S; Bhatnagar S; Dridi S; Hillgartner FB
    J Lipid Res; 2007 Dec; 48(12):2647-63. PubMed ID: 17823458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LXR/RXR activation enhances basolateral efflux of cholesterol in CaCo-2 cells.
    Murthy S; Born E; Mathur SN; Field FJ
    J Lipid Res; 2002 Jul; 43(7):1054-64. PubMed ID: 12091489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of T0901317 on ATP-binding cassette transporter A1 and Niemann-Pick type C1 in apoE-/- mice.
    Dai XY; Ou X; Hao XR; Cao DL; Tang YL; Hu YW; Li XX; Tang CK
    J Cardiovasc Pharmacol; 2008 May; 51(5):467-75. PubMed ID: 18437096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diminished hepatic response to fasting/refeeding and liver X receptor agonists in mice with selective deficiency of sterol regulatory element-binding protein-1c.
    Liang G; Yang J; Horton JD; Hammer RE; Goldstein JL; Brown MS
    J Biol Chem; 2002 Mar; 277(11):9520-8. PubMed ID: 11782483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of human liver X receptor alpha gene expression via an autoregulatory loop mechanism.
    Li Y; Bolten C; Bhat BG; Woodring-Dietz J; Li S; Prayaga SK; Xia C; Lala DS
    Mol Endocrinol; 2002 Mar; 16(3):506-14. PubMed ID: 11875109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LXR agonist suppresses atherosclerotic lesion growth and promotes lesion regression in apoE*3Leiden mice: time course and mechanisms.
    Verschuren L; de Vries-van der Weij J; Zadelaar S; Kleemann R; Kooistra T
    J Lipid Res; 2009 Feb; 50(2):301-11. PubMed ID: 18757914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver X receptors (LXR) as therapeutic targets in dyslipidemia.
    Bełtowski J
    Cardiovasc Ther; 2008; 26(4):297-316. PubMed ID: 19035881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SREBP-2 positively regulates transcription of the cholesterol efflux gene, ABCA1, by generating oxysterol ligands for LXR.
    Wong J; Quinn CM; Brown AJ
    Biochem J; 2006 Dec; 400(3):485-91. PubMed ID: 16901265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endotoxin down-regulates ABCG5 and ABCG8 in mouse liver and ABCA1 and ABCG1 in J774 murine macrophages: differential role of LXR.
    Khovidhunkit W; Moser AH; Shigenaga JK; Grunfeld C; Feingold KR
    J Lipid Res; 2003 Sep; 44(9):1728-36. PubMed ID: 12777468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.